Vascular endothelial growth factor receptor 2 (VEGFR-2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells

Autocrine regulation of glioblastoma cell-cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay

(2010) Petra Knizetova et al.   CELL CYCLE

VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts

(2010) Ingrid Nilsson et al.   EMBO JOURNAL

89Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922

(2010) W. B. Nagengast et al.   JOURNAL OF NUCLEAR MEDICINE

Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma?

(2010) M. Sie et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Kinome Profiling in Pediatric Brain Tumors as a New Approach for Target Discovery

(2009) A. H. Sikkema et al.   CANCER RESEARCH

Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy

(2009) A. K. Lucio-Eterovic et al.   CLINICAL CANCER RESEARCH

Pseudoprogression and pseudoresponse in the treatment of gliomas

(2009) Dieta Brandsma et al.   CURRENT OPINION IN NEUROLOGY

Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis

(2009) Sofie Mellberg et al.   FASEB JOURNAL

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

(2009) Henry S. Friedman et al.   JOURNAL OF CLINICAL ONCOLOGY

Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan

(2009) Roger J. Packer et al.   PEDIATRIC BLOOD & CANCER

VEGF receptor protein–tyrosine kinases: Structure and regulation

(2008) Robert Roskoski   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer

(2008) Elise Langenkamp et al.   CELL AND TISSUE RESEARCH

The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization

(2008) Wenjiao Zeng et al.   HEPATOLOGY

Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis

(2008) Ifat Sher et al.   INTERNATIONAL JOURNAL OF CANCER

Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study

(2008) Julia L. Glade Bender et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

(2008) Teri N. Kreisl et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiplexed Cell Signaling Analysis of Human Breast Cancer Applications for Personalized Therapy

(2008) Julia D. Wulfkuhle et al.   JOURNAL OF PROTEOME RESEARCH

Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay

(2008) Ola Söderberg et al.   METHODS